The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
SBRT as an alternative to RFA for the treatment of primary and metastatic liver tumors.
Erqi Liu
No relevant relationships to disclose
Matthew H. Stenmark
No relevant relationships to disclose
Oliver E Lee
No relevant relationships to disclose
Matthew J Schipper
No relevant relationships to disclose
Elaine M Caoili
No relevant relationships to disclose
Edgar Ben-Josef
No relevant relationships to disclose
Theodore Steven Lawrence
No relevant relationships to disclose
Mary Uan-Sian Feng
No relevant relationships to disclose